CLASS II ONGOING Device recall · Reported 9 Jul 2025 · FDA Enforcement Report

Change Healthcare Cardiology Hemo recalled

Change Healthcare Canada is recalling Change Healthcare Cardiology Hemo, distributed nationwide in the US. The recall was initiated on 22 May 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware version 14.3.2/UDI: (01)17540262100051/ 15.0.1/UDI: (01)17540262100105
Quantity recalled29 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2071-2025
FDA event ID
97046
Recalling firm
Change Healthcare Canada, Richmond
Classification
Class II
Status
Ongoing
Recall initiated
22 May 2025
FDA classified
2 Jul 2025
Reported
9 Jul 2025
Type
Voluntary: Firm initiated
Reason category
Device Malfunction
Device type
Medical Software

Timeline

22 May 2025Recall initiated by company
2 Jul 2025Classified by FDA+41 days
9 Jul 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to complaints, software update may cause software to unexpectedly shutdown.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Change Healthcare Cardiology Hemo Software

Where it was distributed

Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, KY MO, MS, NE, NH, NJ, PA, TN, TX, WA and the countries of Australia, Canada, Germany, Great Britain, Ireland, Israel, New Zealand.

Nationwide AlabamaArkansasCaliforniaFloridaKentuckyMissouriMississippiNebraskaNew HampshireNew JerseyPennsylvaniaTennesseeTexasWashington

Questions about this recall

Why was it recalled?

Due to complaints, software update may cause software to unexpectedly shutdown.

Which lots are affected?

Software version 14.3.2/UDI: (01)17540262100051/ 15.0.1/UDI: (01)17540262100105

Where was it sold?

Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, KY MO, MS, NE, NH, NJ, PA, TN, TX, WA and the countries of Australia, Canada, Germany, Great Britain, Ireland, Israel, New Zealand.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 97046

This product is part of a recall event; the main page for the event is Change Healthcare Cardiology Hemodynamics recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIChange Healthcare Cardiology Hemodynamics recalledChange Healthcare CanadaDevice MalfunctionNationwide

More recalls from Change Healthcare Canada

All 12

Other Medical Software recalls

All 903